Clinical Trials

DCL-17-001: An Open-Label, Dose Escalation, Efficacy, and Safety Study of CLR 131 in Children, Adolescents, and Young Adults With Select Solid Tumors, Lymphoma, and Malignant Brain Tumors

Link :
Population : Ewing Sarcoma, Rhabdomyosarcoma, Osteosarcoma + other (2 -25yrs)
Description : Drug: CLR 131
PI : D. Morgenstern
Centers Opened : SickKids
Phase : I
IIST/Pharma : Pharma